COXSACKIE VIRUS B1-B6 CF ANTIGENS

Antigens, Cf (including Cf Control), Coxsackievirus A 1-24, B 1-6

VIRION (U.S.), INC.

The following data is part of a premarket notification filed by Virion (u.s.), Inc. with the FDA for Coxsackie Virus B1-b6 Cf Antigens.

Pre-market Notification Details

Device IDK921618
510k NumberK921618
Device Name:COXSACKIE VIRUS B1-B6 CF ANTIGENS
ClassificationAntigens, Cf (including Cf Control), Coxsackievirus A 1-24, B 1-6
Applicant VIRION (U.S.), INC. 4 UPPERFIELD RD. Morristown,  NJ  07960
ContactWilliam J Hausler
CorrespondentWilliam J Hausler
VIRION (U.S.), INC. 4 UPPERFIELD RD. Morristown,  NJ  07960
Product CodeGNG  
CFR Regulation Number866.3145 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received1992-04-06
Decision Date1992-06-29

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.